Immunomedics

Immunomedics is a clinical-stage biopharmaceutical company dedicated to developing monoclonal antibody-based targeted therapies for serious diseases such as cancer. The corporate goal of Immunomedics is to become a fully integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates.